⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DYN News
Dyne Therapeutics, Inc. Common Stock
Dyne Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD)
globenewswire.com
DYN
Form 8-K
sec.gov
DYN
Dyne Therapeutics Appoints Barry Greene to Board of Directors
globenewswire.com
DYN
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
DYN
Form 8-K
sec.gov
DYN
Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc.
globenewswire.com
DYN
HTGC
The Authority Images and Vaults Over 10 million Collectibles in Less Than Six Months After Launch
prnewswire.com
DYN
Form 8-K
sec.gov
DYN
Form 8-K
sec.gov
DYN
Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1)
globenewswire.com
DYN